|
60
|
222
|
5l5zL |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
40
|
204
|
5m32I |
Human 26s proteasome in complex with oprozomib |
|
59
|
196
|
5l5sN |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
60
|
234
|
5lf6E |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
59
|
195
|
5l5dJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
67
|
233
|
5l5tM |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
211
|
5l63K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
65
|
244
|
5lf3G |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
70
|
244
|
5l55B |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
66
|
240
|
5l5tC |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
69
|
242
|
5l5jD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
70
|
244
|
5l6bB |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
59
|
196
|
5lajN |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
64
|
244
|
5lexG |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
71
|
243
|
5laiF |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
61
|
226
|
5l5rH |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
64
|
241
|
5l6aG |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
70
|
243
|
5l6cF |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
56
|
204
|
5lf3I |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
65
|
241
|
5l5jG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
67
|
242
|
5l5xD |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
61
|
234
|
5lf1E |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
71
|
244
|
5l5hB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
242
|
5l67D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
244
|
5laiB |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
63
|
231
|
5lttE |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
66
|
231
|
5l5aE |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
63
|
231
|
5l5sE |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
49
|
233
|
5ln3F |
The human 26s proteasome at 6.8 ang. |
|
66
|
231
|
5l5bE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
57
|
204
|
5l5tI |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
68
|
242
|
5l5sD |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
65
|
211
|
5l5yK |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
64
|
242
|
5l54D |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
63
|
241
|
5l5sG |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
57
|
196
|
5l68N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
68
|
213
|
5le5L |
Native human 20s proteasome at 1.8 angstrom |
|
59
|
196
|
5bxnN |
Yeast 20s proteasome beta2-g170a mutant in complex with bortezomib |
|
63
|
231
|
5l6bE |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
61
|
222
|
5laiL |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
65
|
200
|
5lf6K |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
66
|
233
|
5l66M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
68
|
211
|
5laiK |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
73
|
248
|
5lf0B |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
66
|
250
|
5l5hA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
61
|
222
|
5l5vL |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
58
|
226
|
5lajH |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
61
|
230
|
5lf0A |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
68
|
240
|
5lttC |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
59
|
196
|
5l65N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
